Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Notre Dame Intermedica Participacoes stock price, quote, forecast and news

GNDI3.SA
BRGNDIACNOR2

Price

66.95
Today +/-
+0
Today %
+0 %
P

Notre Dame Intermedica Participacoes stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Notre Dame Intermedica Participacoes stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Notre Dame Intermedica Participacoes stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Notre Dame Intermedica Participacoes stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Notre Dame Intermedica Participacoes's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Notre Dame Intermedica Participacoes Stock Price History

DateNotre Dame Intermedica Participacoes Price
2/11/202266.95 undefined
2/10/202266.95 undefined

Notre Dame Intermedica Participacoes Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Notre Dame Intermedica Participacoes, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Notre Dame Intermedica Participacoes from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Notre Dame Intermedica Participacoes’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Notre Dame Intermedica Participacoes. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Notre Dame Intermedica Participacoes’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Notre Dame Intermedica Participacoes’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Notre Dame Intermedica Participacoes’s growth potential.

Notre Dame Intermedica Participacoes Revenue, EBIT and net profit per share

DateNotre Dame Intermedica Participacoes RevenueNotre Dame Intermedica Participacoes EBITNotre Dame Intermedica Participacoes Net Income
2025e24.24 B undefined14.26 B undefined7.83 B undefined
2024e20.67 B undefined5.7 B undefined3.13 B undefined
2023e18.15 B undefined2.35 B undefined1.29 B undefined
2022e15.83 B undefined1.78 B undefined924.71 M undefined
2021e13.2 B undefined408.08 M undefined150.86 M undefined
202010.67 B undefined1.38 B undefined736.19 M undefined
20198.41 B undefined906.72 M undefined423.58 M undefined
20186.14 B undefined617.46 M undefined334.07 M undefined
20175.3 B undefined501.92 M undefined238.17 M undefined
20164.14 B undefined270.99 M undefined85.74 M undefined
20152.98 B undefined178.96 M undefined58.33 M undefined

Notre Dame Intermedica Participacoes Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
2015201620172018201920202021e2022e2023e2024e2025e
2.984.145.36.148.4110.6713.215.8318.1520.6724.24
-38.7128.1515.6737.1126.8823.7019.8714.6913.8717.28
25.8025.5426.3027.1127.4329.14-----
0.771.061.41.662.313.1100000
0.180.270.50.620.911.380.411.782.355.714.26
5.976.529.4510.0610.7712.943.0911.2712.9427.5958.82
0.060.090.240.330.420.740.150.921.293.137.83
-46.55180.0040.3426.6574.00-79.62516.0039.61142.79150.06
-----------
-----------
504.87504.87504.87528.48553.57619.1400000
-----------
Details

Keystats

Revenue and Growth

The Notre Dame Intermedica Participacoes Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Notre Dame Intermedica Participacoes is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (B)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
201520162017201820192020
           
0.630.671.261.374.83.56
167.15210.61372.37475.91678.85881.77
26.2634.6339.3161.84121.03113.63
23.1827.5128.7637.750.77100.52
59.51108.38175.27349.9323.16458.27
0.911.051.872.35.975.12
0.340.460.670.932.242.71
024.7749.2728.890.01153.64
000000
590.41521.11460.79464.63637.71771.98
0.680.751.071.282.75.47
0.590.610.690.761.62.12
2.22.372.953.467.1711.23
3.113.424.825.7613.1516.35
           
0.990.991.041.775.535.65
000000
0.030.110.320.580.851.46
-35.29000-0.23-2.78
000000
0.991.11.352.346.377.1
53.5746.9364.5287.7133.82162.33
90.0881.3112.82136.97206.24255.59
0.60.810.951.061.672.03
000000
73.35112.43427.41617.18423.71344.54
0.821.051.561.92.432.8
0.640.541.060.322.253.67
222.35204.16199.61206.74262.8363.31
0.450.530.660.991.832.42
1.311.271.911.524.346.46
2.132.323.473.426.789.25
3.113.424.825.7613.1516.36
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Notre Dame Intermedica Participacoes provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Notre Dame Intermedica Participacoes's financial health and stability.

Assets

Notre Dame Intermedica Participacoes's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Notre Dame Intermedica Participacoes must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Notre Dame Intermedica Participacoes after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Notre Dame Intermedica Participacoes's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (B)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201520162017201820192020
5885238334423735
114133114127245343
-2948163204295509
16-130-486-779-1,246-1,304
145267281492619695
611158455128154
604498119213441
304405310378337979
-82-261-153-153-186-215
-531-218-1,046-208-1,505-2,777
-44943-893-54-1,318-2,561
000000
0.3-0.060.82-0.641.091.23
00-200-124
0.23-0.170.73-0.064.550.85
-0.06-0.12-0.080.583.53-0.15
0000-79-100
0.010.01-00.113.38-0.95
000000
000000

Notre Dame Intermedica Participacoes stock margins

The Notre Dame Intermedica Participacoes margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Notre Dame Intermedica Participacoes. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Notre Dame Intermedica Participacoes.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Notre Dame Intermedica Participacoes's sales revenue. A higher gross margin percentage indicates that the Notre Dame Intermedica Participacoes retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Notre Dame Intermedica Participacoes's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Notre Dame Intermedica Participacoes's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Notre Dame Intermedica Participacoes's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Notre Dame Intermedica Participacoes. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Notre Dame Intermedica Participacoes's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Notre Dame Intermedica Participacoes Margin History

Notre Dame Intermedica Participacoes Gross marginNotre Dame Intermedica Participacoes Profit marginNotre Dame Intermedica Participacoes EBIT marginNotre Dame Intermedica Participacoes Profit margin
2025e29.14 %58.82 %32.31 %
2024e29.14 %27.59 %15.16 %
2023e29.14 %12.95 %7.11 %
2022e29.14 %11.27 %5.84 %
2021e29.14 %3.09 %1.14 %
202029.14 %12.94 %6.9 %
201927.44 %10.78 %5.04 %
201827.11 %10.06 %5.45 %
201726.31 %9.46 %4.49 %
201625.54 %6.55 %2.07 %
201525.82 %6 %1.95 %

Notre Dame Intermedica Participacoes Stock Sales Revenue, EBIT, Earnings per Share

The Notre Dame Intermedica Participacoes earnings per share therefore indicates how much revenue Notre Dame Intermedica Participacoes has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Notre Dame Intermedica Participacoes earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Notre Dame Intermedica Participacoes's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Notre Dame Intermedica Participacoes’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Notre Dame Intermedica Participacoes's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Notre Dame Intermedica Participacoes Revenue, EBIT and net profit per share

DateNotre Dame Intermedica Participacoes Sales per ShareNotre Dame Intermedica Participacoes EBIT per shareNotre Dame Intermedica Participacoes Earnings per Share
2025e39.1 undefined0 undefined12.63 undefined
2024e33.34 undefined0 undefined5.05 undefined
2023e29.28 undefined0 undefined2.08 undefined
2022e25.53 undefined0 undefined1.49 undefined
2021e21.3 undefined0 undefined0.24 undefined
202017.24 undefined2.23 undefined1.19 undefined
201915.2 undefined1.64 undefined0.77 undefined
201811.61 undefined1.17 undefined0.63 undefined
201710.51 undefined0.99 undefined0.47 undefined
20168.2 undefined0.54 undefined0.17 undefined
20155.91 undefined0.35 undefined0.12 undefined

Notre Dame Intermedica Participacoes business model

Our Lady Intermedica Participacoes SA is a leading healthcare and health insurance company in Brazil. The company was established in 1968 in São Paulo when a group of doctors decided to operate a joint medical facility to facilitate access to healthcare. Over the years, Notre Dame Intermedica has evolved from this humble beginning to a nationally recognized company with a large customer base and various divisions in the industry. Notre Dame Intermedica's business model is based on two pillars: preventive medicine and health insurance. The company offers its customers comprehensive medical services, ranging from home visits and examinations to departments for complex surgical procedures and emergencies. The services are provided in 31 centers across Brazil. Notre Dame Intermedica shines through its excellent expertise in the industry and support from professionals in various medical fields. In terms of divisions and products, Notre Dame Intermedica offers a wide range of services that go beyond the traditional health spectrum. This includes a variety of laboratory services, diagnostic procedures, and tools to support nutrition and health education. Notre Dame Intermedica's extensive experience in developing and implementing patient-focused strategies makes it a reliable partner for healthcare services. Notre Dame Intermedica's health insurance division includes both individual and business insurance. By offering flexible health insurance packages tailored to the needs of customers, Notre Dame Intermedica stands out from other insurance companies. Furthermore, over the years, the company has expanded its product range through strategic partnerships with other companies. Recently, Notre Dame Intermedica has also made strategic acquisitions to expand its business and face increasing competition in the industry. The acquisition of GreenLine, another leading health insurance company in Brazil, in 2018 helped Notre Dame Intermedica strengthen its market position and expand its service offering in the health insurance industry. Overall, Notre Dame Intermedica is a strong company with a deep understanding of the industry that focuses on the needs of its customers. Its long-standing experience, support from professionals in various medical fields, and focus on innovative technologies also make the company attractive to new customers and investors. The company is known for its ability to adapt to changing market conditions and remain flexible. Notre Dame Intermedica Participacoes is one of the most popular companies on Eulerpool.com.

Notre Dame Intermedica Participacoes SWOT Analysis

Strengths

  • Established reputation in the healthcare industry.
  • Strong network of medical professionals and facilities.
  • Diversified portfolio of healthcare services.

Weaknesses

  • Relatively high dependence on the Brazilian market.
  • Limited presence in international markets.
  • Vulnerability to regulatory changes in the healthcare sector.

Opportunities

  • Growing demand for private healthcare services in Brazil.
  • Expansion into untapped regional markets within Brazil.
  • Potential partnerships with insurance companies to offer comprehensive healthcare packages.

Threats

  • Intense competition from other healthcare providers.
  • Economic instability that may affect consumer spending on healthcare.
  • Possible changes in government healthcare policies.

Notre Dame Intermedica Participacoes Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Notre Dame Intermedica Participacoes historical P/E ratio, EBIT, and P/S ratio.

Notre Dame Intermedica Participacoes shares outstanding

The number of shares was Notre Dame Intermedica Participacoes in 2023 — This indicates how many shares 619.142 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Notre Dame Intermedica Participacoes earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Notre Dame Intermedica Participacoes's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Notre Dame Intermedica Participacoes’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Notre Dame Intermedica Participacoes's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Notre Dame Intermedica Participacoes dividend history and estimates

In 2023, Notre Dame Intermedica Participacoes paid a dividend amounting to 0.33 BRL. Dividend means that Notre Dame Intermedica Participacoes distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Notre Dame Intermedica Participacoes provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Notre Dame Intermedica Participacoes’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Notre Dame Intermedica Participacoes's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Notre Dame Intermedica Participacoes Dividend History

DateNotre Dame Intermedica Participacoes Dividend
2025e2.07 undefined
2024e0.83 undefined
2023e0.33 undefined
2022e0.25 undefined
2021e0.04 undefined
20200.17 undefined
20190.15 undefined

Notre Dame Intermedica Participacoes dividend payout ratio

In 2023, Notre Dame Intermedica Participacoes had a payout ratio of 15.89%. The payout ratio indicates the percentage of the company's profits that Notre Dame Intermedica Participacoes distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Notre Dame Intermedica Participacoes represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Notre Dame Intermedica Participacoes could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Notre Dame Intermedica Participacoes's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Notre Dame Intermedica Participacoes Payout Ratio History

DateNotre Dame Intermedica Participacoes Payout ratio
2025e16.41 %
2024e16.51 %
2023e15.89 %
2022e16.82 %
2021e16.82 %
202014.02 %
201919.62 %
201816.82 %
201716.82 %
201616.82 %
201516.82 %
Unfortunately, there are currently no price targets and forecasts available for Notre Dame Intermedica Participacoes.

Notre Dame Intermedica Participacoes list of shareholders

%
Name
Stocks
Change
Date
4.97 % BlackRock Institutional Trust Company, N.A.30,791,07307/13/2021
4.91 % Capital Research Global Investors30,462,408-28,198,2414/8/2021
2.64 % The Vanguard Group, Inc.16,351,12563,64611/30/2021
2.01 % Itaú Unibanco S.A.12,478,388-558,70411/30/2021
11.10 % BRL Trust DTVM S.A.68,818,75407/13/2021
1.62 % BlackRock Asset Management North Asia Limited10,034,005148,25711/30/2021
1.47 % Credit Suisse Hedging-Griffo Asset Management S.A.9,116,621011/30/2021
1.45 % Verde Asset Management S.A.9,009,461125,1398/31/2021
1.39 % Nucleo Capital, Ltda.8,607,065209,08211/30/2021
1.26 % Norges Bank Investment Management (NBIM)7,813,4592,065,61412/31/2020
1
2
3
4
5
...
10

Most common questions regarding Notre Dame Intermedica Participacoes

What values and corporate philosophy does Notre Dame Intermedica Participacoes represent?

Notre Dame Intermedica Participacoes SA is committed to upholding values of excellence, integrity, and compassion in the healthcare industry. The company's corporate philosophy focuses on providing high-quality and accessible healthcare services to improve the well-being of its patients. Notre Dame Intermedica Participacoes SA believes in fostering strong doctor-patient relationships, ensuring patient-centric care, and promoting innovation in medical practices. With a customer-centric approach, the company strives to deliver comprehensive healthcare solutions while maintaining a strong ethical foundation. Notre Dame Intermedica Participacoes SA consistently works towards improving healthcare outcomes and contributing positively to the community it serves.

In which countries and regions is Notre Dame Intermedica Participacoes primarily present?

Notre Dame Intermedica Participacoes SA is primarily present in Brazil.

What significant milestones has the company Notre Dame Intermedica Participacoes achieved?

Notre Dame Intermedica Participacoes SA has achieved several significant milestones. The company has experienced consistent growth and expansion since its establishment. It successfully completed its initial public offering (IPO) in 2018, raising substantial funds for further development. Notre Dame Intermedica Participacoes SA has also made strategic acquisitions, including the acquisition of Medisanitas Brazil, which expanded its presence in the healthcare market. Furthermore, the company has been consistently recognized for its high-quality healthcare services and commitment to patient care. Notre Dame Intermedica Participacoes SA continues to strengthen its position as a leading healthcare provider in Brazil through continuous innovation and strategic initiatives.

What is the history and background of the company Notre Dame Intermedica Participacoes?

Notre Dame Intermedica Participacoes SA, commonly known as Notre Dame Intermedica, is a leading healthcare company in Brazil. Established in 1968, the company has a rich history of providing high-quality healthcare services to individuals, families, and companies. With a commitment to excellence, Notre Dame Intermedica has grown to become one of the largest healthcare providers in the country, offering a wide range of medical, dental, and diagnostic services. Backed by a strong network of healthcare professionals and cutting-edge technology, the company continuously strives to improve the accessibility and affordability of healthcare in Brazil. Notre Dame Intermedica's dedication to customer satisfaction and its innovative approach to healthcare make it a reliable and trusted choice in the industry.

Who are the main competitors of Notre Dame Intermedica Participacoes in the market?

The main competitors of Notre Dame Intermedica Participacoes SA in the market include Grupo Fleury SA, Hapvida Participacoes e Investimentos SA, and Sul America SA.

In which industries is Notre Dame Intermedica Participacoes primarily active?

Notre Dame Intermedica Participacoes SA is primarily active in the healthcare industry.

What is the business model of Notre Dame Intermedica Participacoes?

The business model of Notre Dame Intermedica Participacoes SA is focused on providing healthcare services in Brazil. The company operates as a health insurance provider, offering a range of medical plans to individuals, families, and corporations. Notre Dame Intermedica also owns and operates a network of healthcare facilities, including hospitals, clinics, and diagnostic centers. With a strong emphasis on quality care and customer satisfaction, the company strives to meet the healthcare needs of its customers by offering comprehensive services, advanced medical technologies, and a wide network of healthcare professionals. Notre Dame Intermedica is committed to improving access to healthcare services and promoting overall well-being in Brazil.

What is the P/E ratio of Notre Dame Intermedica Participacoes 2024?

The Notre Dame Intermedica Participacoes P/E ratio is 13.23.

What is the P/S ratio of Notre Dame Intermedica Participacoes 2024?

The Notre Dame Intermedica Participacoes P/S ratio is 2.01.

What is the AlleAktien quality score of Notre Dame Intermedica Participacoes?

The AlleAktien quality score for Notre Dame Intermedica Participacoes is 4/10.

What is the revenue of Notre Dame Intermedica Participacoes 2024?

The expected Notre Dame Intermedica Participacoes revenue is 20.67 B BRL.

How high is the profit of Notre Dame Intermedica Participacoes 2024?

The expected Notre Dame Intermedica Participacoes profit is 3.13 B BRL.

What is the business model of Notre Dame Intermedica Participacoes

Notre Dame Intermedica Participacoes SA is a Brazilian company that operates in the healthcare sector. Its business model includes various interconnected and complementary areas. One of the core elements of Notre Dame Intermedica's business model is the provision of healthcare services. The company offers a variety of services including outpatient, clinical, and diagnostic services. These services are provided in different hospitals and medical facilities located in various cities in Brazil. Another important element of Notre Dame Intermedica's business model is the provision of health insurance. The company offers health insurance plans for individuals and groups that provide comprehensive coverage for various types of medical treatments. These insurance plans also include additional services such as dental care, medical advice, and emergency medical care. Notre Dame Intermedica also has its own pharmacy, which sells pharmaceutical products and services to customers. These products range from prescription medications to health and beauty products. The company also operates a network of pharmacies that provide customers with medical products and services. These pharmacies can be found in different cities in Brazil and offer a wide range of medical products and services. Another element of Notre Dame Intermedica's business model is the provision of health programs and healthcare management services. The company offers programs for managing chronic diseases, including diabetes, hypertension, and cancer. These programs also include nutritional counseling, medical monitoring, and rehabilitation. Notre Dame Intermedica also relies on technology and innovation to improve its business models and services. The company invests in the development of information technology and data analysis to enhance the effectiveness of its services and programs and provide better customer service. The business model of Notre Dame Intermedica is based on providing high-quality healthcare services and products, as well as improving the health and well-being of its customers. The company aims to be a leader in the healthcare industry in Brazil by offering innovative solutions and services that meet the needs of its customers.

What is the Notre Dame Intermedica Participacoes dividend?

Notre Dame Intermedica Participacoes pays a dividend of 1.61 BRL distributed over payouts per year.

How often does Notre Dame Intermedica Participacoes pay dividends?

The dividend cannot currently be calculated for Notre Dame Intermedica Participacoes or the company does not pay out a dividend.

What is the Notre Dame Intermedica Participacoes ISIN?

The ISIN of Notre Dame Intermedica Participacoes is BRGNDIACNOR2.

What is the Notre Dame Intermedica Participacoes ticker?

The ticker of Notre Dame Intermedica Participacoes is GNDI3.SA.

How much dividend does Notre Dame Intermedica Participacoes pay?

Over the past 12 months, Notre Dame Intermedica Participacoes paid a dividend of 0.17 BRL . This corresponds to a dividend yield of about 0.25 %. For the coming 12 months, Notre Dame Intermedica Participacoes is expected to pay a dividend of 2.07 BRL.

What is the dividend yield of Notre Dame Intermedica Participacoes?

The current dividend yield of Notre Dame Intermedica Participacoes is 0.25 %.

When does Notre Dame Intermedica Participacoes pay dividends?

Notre Dame Intermedica Participacoes pays a quarterly dividend. This is distributed in the months of April, April, June, March.

How secure is the dividend of Notre Dame Intermedica Participacoes?

Notre Dame Intermedica Participacoes paid dividends every year for the past 7 years.

What is the dividend of Notre Dame Intermedica Participacoes?

For the upcoming 12 months, dividends amounting to 2.07 BRL are expected. This corresponds to a dividend yield of 3.1 %.

In which sector is Notre Dame Intermedica Participacoes located?

Notre Dame Intermedica Participacoes is assigned to the 'Health' sector.

Wann musste ich die Aktien von Notre Dame Intermedica Participacoes kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Notre Dame Intermedica Participacoes from 3/29/2022 amounting to 1.613 BRL, you needed to have the stock in your portfolio before the ex-date on 2/14/2022.

When did Notre Dame Intermedica Participacoes pay the last dividend?

The last dividend was paid out on 3/29/2022.

What was the dividend of Notre Dame Intermedica Participacoes in the year 2023?

In the year 2023, Notre Dame Intermedica Participacoes distributed 1.613 BRL as dividends.

In which currency does Notre Dame Intermedica Participacoes pay out the dividend?

The dividends of Notre Dame Intermedica Participacoes are distributed in BRL.

All fundamentals about Notre Dame Intermedica Participacoes

Our stock analysis for Notre Dame Intermedica Participacoes Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Notre Dame Intermedica Participacoes Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.